Sanofi struggles in Q3 results in face of slowdown in emerging markets
A slowdown in growth in emerging markets has contributed to lower-than expected financial results for Sanofi in the third quarter.
Read MoreAuthor: Katrina Megget
Teva chief denies resignation rumours
A rumour that Teva’s chief executive Jeremy Levin was stepping down due to a rift in the company’s board has been denied as a “baseless claim”.
Read MoreNovartis faces Chinese bribery allegations
Novartis is the latest company to face bribery allegations in China after a whistleblower accused the firm of offering kickbacks to doctors to ensure cancer drugs were prescribed.
Read MoreWinners revealed in salesforce competition
Thirty-six companies participated in the new PharmaTimes Sales Awards, which encompass PharmaTimes Sales Representative of the Year and PharmaTimes Business Manager of the Year competitions, with the winners announced at a presentation ceremony in London on 11 July.
Read MoreLife sciences skills development recognised at inaugural awards
Companies and individuals have been recognised for their excellence in advancing the future skills required for the life sciences industry at the inaugural UK Life Sciences Skills Awards, organised by Cogent.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
